>
AngioDynamics Inc logo

ANGO - AngioDynamics Inc Share Price

$22.95 0.2  0.7%

Last Trade - 14/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £618.6m
Enterprise Value £601.2m
Revenue £194.0m
Position in Universe 2945th / 6849
Bullish
Bearish
Unlock ANGO Revenue
Momentum
Relative Strength (%)
1m -3.72%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -9.74%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
317.5
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st May 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
356.5 353.9 269.8 261.7 270.6 264.2 286.9 297.9 -5.8%
+86.9 +55.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 28 February 2021,AngioDynamics, Inc. revenues increased 4% to $214.2M. Netloss increased 24% to $12.1M. Revenues reflect UnitedStates segment increase of 6% to $173.4M. Higher net lossreflects Sales and marketing - Balancing value increase of40% to $57.2M (expense), Research and development -Balancing val increase of 69% to $26.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ANGO Revenue Unlock ANGO Revenue

Net Income

ANGO Net Income Unlock ANGO Revenue

Normalised EPS

ANGO Normalised EPS Unlock ANGO Revenue

PE Ratio Range

ANGO PE Ratio Range Unlock ANGO Revenue

Dividend Yield Range

ANGO Dividend Yield Range Unlock ANGO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ANGO EPS Forecasts Unlock ANGO Revenue
Profile Summary

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Vascular Interventions & Therapies, Vascular Access and Oncology. The Company's Vascular Interventions & Therapies products include Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines. Through its subsidiary, Eximo Medical, Ltd., the Company operates 355 nanometers (nm) wavelength laser-technology platform.

Directors
Last Annual May 31st, 2020
Last Interim February 28th, 2021
Incorporated July 30, 1992
Public Since May 27, 2004
No. of Shareholders: 174
No. of Employees: 800
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 38,137,367
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ANGO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ANGO
Upcoming Events for ANGO
Wednesday 14th July, 2021 Estimate
Q4 2021 AngioDynamics Inc Earnings Release
Monday 27th September, 2021 Estimate
Q1 2022 AngioDynamics Inc Earnings Release
Wednesday 13th October, 2021 Estimate
AngioDynamics Inc Annual Shareholders Meeting
Frequently Asked Questions for AngioDynamics Inc
What is the AngioDynamics Inc share price?

As of 14/05/21, shares in AngioDynamics Inc are trading at $22.95, giving the company a market capitalisation of £618.6m. This share price information is delayed by 15 minutes.

How has the AngioDynamics Inc share price performed this year?

Shares in AngioDynamics Inc are currently trading at $22.95 and the price has moved by 0.123k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the AngioDynamics Inc price has moved by 56.71% over the past year.

What are the analyst and broker recommendations for AngioDynamics Inc?

Of the analysts with advisory recommendations for AngioDynamics Inc, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for AngioDynamics Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will AngioDynamics Inc next release its financial results?

AngioDynamics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-02-28
What is the AngioDynamics Inc dividend yield?

AngioDynamics Inc does not currently pay a dividend.

Does AngioDynamics Inc pay a dividend?

AngioDynamics Inc does not currently pay a dividend.

When does AngioDynamics Inc next pay dividends?

AngioDynamics Inc does not currently pay a dividend.

How do I buy AngioDynamics Inc shares?

To buy shares in AngioDynamics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of AngioDynamics Inc?

Shares in AngioDynamics Inc are currently trading at $22.95, giving the company a market capitalisation of £618.6m.

Where are AngioDynamics Inc shares listed? Where are AngioDynamics Inc shares listed?

Here are the trading details for AngioDynamics Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ANGO
What kind of share is AngioDynamics Inc?

Based on an overall assessment of its quality, value and momentum, AngioDynamics Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a AngioDynamics Inc share price forecast 2021?

Shares in AngioDynamics Inc are currently priced at $22.95. At that level they are trading at 11.89% discount to the analyst consensus target price of 0.00.

Analysts covering AngioDynamics Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.047 for the next financial year.

How can I tell whether the AngioDynamics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AngioDynamics Inc. Over the past six months, the relative strength of its shares against the market has been 67.71%. At the current price of $22.95, shares in AngioDynamics Inc are trading at 43.02% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the AngioDynamics Inc PE Ratio?

We were not able to find PE ratio data for AngioDynamics Inc.

Who are the key directors of AngioDynamics Inc?

AngioDynamics Inc's management team is headed by:

Howard Donnelly - CHM
Dennis Meteny - IND
Wesley Johnson - IND
Stephen Trowbridge - CFO
Benjamin Davis - SVP
James Clemmer - PRE
Eileen Auen - IND
Jan Reed - IND
Chad Campbell - SVP
David Helsel - SVP
Brent Boucher - SVP
Karen Licitra - IND
Marna Bronfen-Moore - SVP
Scott Centea - SVP
Richard Rosenzweig - SVP
Who are the major shareholders of AngioDynamics Inc?

Here are the top five shareholders of AngioDynamics Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 16.13% (6.15m shares)
Victory Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 8.13% (3.10m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 7.67% (2.93m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 6.61% (2.52m shares)
Victory Sycamore Small Company Opportunity Fund Mutual Fund
Percentage owned: 6.52% (2.49m shares)
Similar to ANGO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.